Following the acquisition of the assets and certain liabilities of AMT by uniQure BV, AMT's legal entity will be liquidated and delisted.

For more information please click here

 

Latest News

Amsterdam Molecular Therapeutics Reports Full Year Results 2011
Apr 27, 2012 > Read More
Overview of key transaction elements and timetable with regard to the public-to-private and financing transaction between AMT and uniQure BV
Apr 26, 2012 > Read More
From Care to Cure